Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer's Disease
Therefore, Kaempferol and myricetin emerge as promising candidates for further investigations in both in vitro and in vivo studies to treat Alzheimer's disease and other neurodegenerative disorders.
Authors
- Umesh R. Desai (ORCID: https://orcid.org/0000-0002-1976-6597)
- Balaji Nagarajan (ORCID: https://orcid.org/0000-0003-3892-6178)
- Ashok Kumar Pandurangan (ORCID: https://orcid.org/0000-0003-2824-1757)
- Mohd Kashif (ORCID: https://orcid.org/0000-0003-2856-8274)
Institutions
- Virginia Commonwealth University (US)
- B.S. Abdur Rahman Crescent Institute of Science & Technology (IN)
Publication Details
- Journal
- CNS & Neurological Disorders - Drug Targets
- Published
- 2025-08-15
- DOI
- https://doi.org/10.2174/0118715273371881250723061908
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00